Home > Drug Search >
  • company_query: Beijing Meidisai Medical Technology
  •   > 
Drug Filter
Category:
chemistry (22) biology (11)
Status:
Phase Ⅲ (5) Phase Ⅱ (19) Phase Ⅰ (8) IND Filing (1)
Clinical Stage:
Pending (5) Active (22) Discontinued (5)
Bio-Type:
Gene therapy (1) Vaccine (1) Whole antibody (5)
Indication:
Alzheimer's disease (AD) (3) Anxiety (1) Asthma (1) Atherosclerosis (1) Attention deficit hyperactivity disorder (ADHD) (1) Cancer related pain (1) Cerebral infarction (1) Chronic lymphocytic leukemia (CLL) (1) Chronic myeloid leukemia (CML ) (1) Chronic obstructive pulmonary disease (COPD) (1) Circulation disturbance (1) Herpes simplex virus (1) Gastric cancer (1) Gastrointestinal stromal tumors (GISTs) (1) Dyskinesia (1) HIV infection (1) Major depressive disorder (MDD) (2) Malignancies (1) Haematological disorders (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (2) Peptic ulcer (1) Pleural mesothelioma (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (2) Sjoegren's syndrome (1) Solid tumours (2) Systemic lupus erythematosus (1) Thyroid cancer (1) Tourette's syndrome (1) Cardiac ischemic complications (1) Colorectal cancer (2) Pain (1) Diabetes (1) Hematological cancer (1) Autoimmune diseases (1) Staphylococcal infection (1) Glioblastoma (1) Allergic asthma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top